Rosen Law Firm reminds purchasers of Insulet Corporation securities between February 21, 2025 and May 26, 2026 of the August 31, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Insulet made false or misleading statements and failed to disclose defective manufacturing controls and procedures, which created a risk that products would violate safety regulations or cause injury. Investors who purchased Insulet securities during the class period may be entitled to compensation through a contingency fee arrangement. Rosen Law Firm highlights its track record in securities class actions, including achieving the largest ever settlement against a Chinese company and recovering billions of dollars for investors.
Insulet CorporationLawsuit alleges defective manufacturing controls and safety violations, posing legal and regulatory risk.